< 1 minute read
Jan. 17, 2022
Compound 24: a Brain-Penetrant, Type I LRRK2 Kinase Inhibitor
“compound 24”
LRRK2 kinase inhibitor preclinical, brain-penetrant from rational HTL and structure-guided opt. Journal of Medicinal Chemistry Merck & Co., Boston, MA
Reviewer:
Loading...
